SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019438
Filing Date
2023-12-04
Accepted
2023-12-04 08:00:44
Documents
14
Period of Report
2023-12-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20231203x8k.htm   iXBRL 8-K 42696
2 EX-4.1 agrx-20231203xex4d1.htm EX-4.1 133829
3 EX-10.1 agrx-20231203xex10d1.htm EX-10.1 56824
  Complete submission text file 0001558370-23-019438.txt   394916

Data Files

Seq Description Document Type Size
4 EX-101.SCH agrx-20231203.xsd EX-101.SCH 3162
5 EX-101.LAB agrx-20231203_lab.xml EX-101.LAB 15929
6 EX-101.PRE agrx-20231203_pre.xml EX-101.PRE 10133
8 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20231203x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 231461344
SIC: 2834 Pharmaceutical Preparations